Schedule 13G ownership disclosure
UNICYCIVE THERAPEUTICS INC
Security class unavailable · CUSIP: 90466Y103
Event date: 2024-10-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-098628
- Form type
- SC 13G
- Filer
- Unicycive Therapeutics, Inc.
- CIK
- CIK 1766140
- Filed
- Nov 14, 2024
- Reporting period
- Oct 09, 2024
- Description
- Schedule 13G beneficial ownership